Kelly Zalocusky, Ph.D., is the Senior Director of Computational Biology, Joint Technical Team Lead of Recurison's 10-year neuroscience collaboration with Roche/Genentech, and Site Lead for Recursion's newly-opened London Office. Scientifically, her focus is on deploying high-throughput imaging and AI models for novel drug development in neuroscience, and she leads scientific teams focused on applying Recursion's novel platform and approach to the discovery of therapies to radically improve patients’ lives. She is a Neuroscientist by training and received her bachelor's degree from Hendrix College, and Ph.D. from Stanford University.